Global Information
회사소개 | 문의 | 비교리스트

세포 수확 시장 : 성장, 동향, 예측(2019-2024년)

Cell Harvesting Market - Growth, Trends, and Forecast (2019 - 2024)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2019년 05월 상품 코드 907077
페이지 정보 영문
US $ 4,250 ₩ 5,050,000 PDF (Single User License)
US $ 4,750 ₩ 5,644,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,130,000 PDF (Site License)
US $ 7,500 ₩ 8,913,000 PDF (Corporate License)

세포 수확 시장 : 성장, 동향, 예측(2019-2024년) Cell Harvesting Market - Growth, Trends, and Forecast (2019 - 2024)
발행일 : 2019년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 세포 수확(Cell Harvesting) 시장에 대해 조사했으며, 시장 동향과 부문별 동향, 지역별 예측, 시장 진출기업 개요에 대해 정리했습니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 동향

  • 시장 개요
  • 시장 성장 촉진요인
  • 시장 성장 저해요인
  • Porter's Five Forces 분석

제5장 시장 세분화

  • 종류별
    • 수동 세포 수확장치
    • 자동 세포 수확장치
  • 용도별
    • 바이오의약품
    • 줄기세포 연구
    • 기타
  • 최종사용자
    • 바이오테크놀러지 기업 및 바이오 의약품 기업
    • 연구기관
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제6장 경쟁 환경

  • 기업 개요
    • Arthrex Inc.
    • AVITA Medical
    • GE Healthcare
    • Pall Corporation
    • Perkin Elmer Inc.
    • Sartorius AG
    • Terumo Corporation
    • Tomtec

제7장 시장 기회와 향후 동향

LSH 19.08.29

Market Overview

The major factors for the growth of the cell harvesting market include the rising investments in regenerative medicine and cell-based research, growth of the biotechnology and biopharmaceutical industries, and increasing incidence of chronic and infectious diseases.

According to the World Health Organization (WHO), chronic diseases are expected to increase by 57% by 2020. Increased demand for healthcare systems due to chronic diseases has become a major concern. The Center for Disease Control and Prevention (CDC), states that in 2017, chronic diseases were the leading cause of death and disability in the United States, and 133 million Americans, i.e., 45% of the population, had at least one chronic disease. In addition, the rise of age and lifestyle-related chronic diseases is increasing the demand and spending for healthcare. In developing markets, cancer and heart disease are becoming the main causes of death as a result of urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. The potential use of stem cells in treating various chronic disease is the major factor for the growth of the market. Thus, increasing prevalence of the chronic and infectious disease is expected to spur market growth.

Scope of the Report

As per the scope of this report, cell harvesting is a technique of collecting cells. Cell harvesting is considered as an important step in the biopharmaceutical manufacturing industry, which is likely to directly affect the product quality and related downstream processes. The market is segmented by type of cell harvesting, application, end-user, and geography.

Key Market Trends

Stem Cell Research is the Segment by Application is expected to be the Fastest-Growing Segment Over the Forecast Period

Human stem cell research holds enormous potential for contributing to the understanding of fundamental human biology. Studying the stem cells are helping scientists to understand more about how the body works and how the disease develops and affects the body. Working on stem cell research is helping researchers to better understand different diseases and conditions, and in finding new treatments. Human stem cell research should be integrated into the mainstream of biomedical research, including disease modeling, the study of cellular degenerative processes, development of pharmaceutical and toxicological screening platforms, and regenerative therapy. As per the data published by the National Institute of Health, around 60,000 patients are treated with bone marrow transplantation (BMT) per year worldwide. The bone marrow-derived stem cells can advance the study of stem cell biology, stem cell-based therapies, and regenerative medicine. Thus, owing to the all above-mentioned factors the market is expected to witness high growth over the forecast period.

North America is Expected to Dominate the Market

North America is found to hold a major share for the cell harvesting market and is expected to show a similar trend over the forecast period, without significant fluctuations. The market in the United States is dominating the cell harvesting market, due to increasing research expenditure and government initiatives. Currently, the only stem cell-based products that are approved by the FDA for use in the United States consist of blood-forming stem cells, derived from cord blood. These, as well as, stem cells, which come from bone marrow, are commonly used in transplant procedures to treat patients with cancer and disorders of the blood and immune system. Furthermore, there is a rise in healthcare spending in the United States. These above-mentioned factors are the key elements that are augmenting the growth of the market and making it stable, in the United States. However, in the United States, a research conducted in 2016 found hundreds of the clinics in the United States selling unapproved stem cell treatments, which is likely to hinder the growth of the market in the United States, which is likely to restraint for market growth.

Competitive Landscape

The market studied is a moderately consolidated market owing to the presence of small and large market players. Some of the market players are Arthrex Inc., AVITA Medical, GE Healthcare, Pall Corporation, Perkin Elmer Inc., Sartorius AG, Terumo Corporation, and Tomtec

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Investments in Regenerative Medicine and Cell-based Research
    • 4.2.2 Growth of the Biotechnology and Biopharmaceutical Industries
    • 4.2.3 Increasing Incidence of Chronic and Infectious Diseases
  • 4.3 Market Restraints
    • 4.3.1 Ethical Issues pertaining to Embryonic Stem Cell Research
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Type of Cell Harvesting
    • 5.1.1 Manual Cell Harvesters
    • 5.1.2 Automated Cell Harvesters
  • 5.2 By Application
    • 5.2.1 Biopharmaceutical Application
    • 5.2.2 Stem Cell Research
    • 5.2.3 Other Applications
  • 5.3 By End User
    • 5.3.1 Biotechnology & Biopharmaceutical Companies
    • 5.3.2 Research Institutes
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • US
      • Canada
      • Mexico
    • 5.4.2 Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.4.3 Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • 5.4.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Arthrex Inc.
    • 6.1.2 AVITA Medical
    • 6.1.3 GE Healthcare
    • 6.1.4 Pall Corporation
    • 6.1.5 Perkin Elmer Inc.
    • 6.1.6 Sartorius AG
    • 6.1.7 Terumo Corporation
    • 6.1.8 Tomtec


Back to Top
전화 문의